Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals

JAMA Psychiatry

Volumn 70, Issue 2, 2013, Pages 176-184

  Wium Andersen, Marie Kim ^a,b   Ørsted, David Dynnes ^a,b   Nielsen, Sune Fallgaard ^a,b   Nordestgaard, Børge Grønne ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SELF REPORT;

EID: 84874056953     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamapsychiatry.102     Document Type: Article

References (43)

1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
2. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65(9):732-741.
3. Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep. 2011;13(6):467-475.
4. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111(12):1805-1812.
5. Nordestgaard BG. Does elevated C-reactive protein cause human atherothrom-bosis? novel insights from genetics, intervention trials, and elsewhere. Curr Opin Lipidol. 2009;20(5):393-401.
6. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG, Ferrie JE. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II Study. Psychol Med. 2009;39(3):413-423.
7. Puustinen PJ, Koponen H, Kautiainen H, Mäntyselkä P, Vanhala M. Psychological distress and C-reactive protein: do health behaviours and pathophysiological factors modify the association? Eur Arch Psychiatry Clin Neurosci. 2011; 261(4):277-284.
8. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L. The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychol Med. 2007; 37(12):1775-1786.
9. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med. 2004;66(5):679-683.
10. Matthews KA, Schott LL, Bromberger J, Cyranowski J, Everson-Rose SA, Sowers MF. Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. Psychosom Med. 2007;69(2):124-130.
11. Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MMB. Inflammatory proteins and depression in the elderly. Epidemiology. 2003;14(1):103-107.
12. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003;65(3):347-356.
13. Elovainio M, Aalto AM, Kivimäki M, Pirkola S, Sundvall J, Lönnqvist J, Reunanen A. Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med. 2009;71(4):423-430.
14. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen P, Leinonen M, Meyer-Rochow VB, Timonen M. The association between C-reactive protein levels and depression: results from the Northern Finland 1966 Birth Cohort Study. Biol Psychiatry. 2006;60(8):825-830.
15. Bjerkeset O, Romild U, Smith GD, Hveem K. The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study. Psychol Med. 2011;41(2):345-352.
16. Matthews KA, Schott LL, Bromberger JT, Cyranowski JM, Everson-Rose SA, Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav Immun. 2010;24(1):96-101.
17. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009;23(7):936-944.
18. Hamer M, Batty GD, Marmot MG, Singh-Manoux A, Kivimäki M. Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun. 2011;25(1):168-173.
19. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308.
20. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009; 27(13):2217-2224.
21. World Health Organisation Collaborating Center for Drug Statistics and Methodology. Guidelines for ATC Classification and DDD Assignment. 14th ed. Oslo: Norwegian Institute of Public Health; 2011.
22. World Health Organization. International Classification of Diseases, Eighth Revision (ICD-8). Geneva, Switzerland: World Health Organization; 1965.
23. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
24. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study Østerbroundersøgelsen: tables with data from the third examination, 1991-1994. Eur Heart J Suppl. 2001;3(suppl H):1-83.
25. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363-369.
26. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341-353.
27. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585-598.
28. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4(1):87-90.
29. Hamer M, Molloy GJ, Stamatakis E. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J Am Coll Cardiol. 2008;52(25):2156-2162.
30. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsycho-pharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology. 2012;37(1):137-162.
31. Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharma-cological implications. Pharmacol Ther. 2011;130(2):226-238.
32. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev. 2009;61(2):105-123.
33. Kyrou I, Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol. 2009;9(6):787-793.
34. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003;17(4):276-285.
35. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454.
36. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487-48490.
37. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5(10):621-635.
38. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. J Psychosom Res. 2009;66(3):189-194.
39. Ohayon MM, Priest RG, Guilleminault C, Caulet M. The prevalence of depressive disorders in the United Kingdom. Biol Psychiatry. 1999;45(3):300-307.
40. Liukkonen T, Räsänen P, Jokelainen J, Leinonen M, Järvelin MR, Meyer-Rochow VB, Timonen M. The association between anxiety and C-reactive protein (CRP) levels: results from the Northern Finland 1966 Birth Cohort Study. Eur Psychiatry. 2011;26(6):363-369.
41. Herrán A, Sierra-Biddle D, García-Unzueta MT, Puente J, Vázquez-Barquero JL, Antonio Amado J. The acute phase response in panic disorder. Int J Neuropsychopharmacol. 2005;8(4):529-535.
42. Hansen DG, Vach W, Rosholm JU, Søndergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract. 2004;21(6):623-629.
43. Danish National Board of Health. Sundhedsstyrelsens referenceprogram for unipolar depression hos voksne 2007. Copenhagen, Denmark: Sundhedsstyrelsen; 2007.